Advertisement

Epidemiology

  • Atsushi Tanaka
Chapter

Abstract

Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is a relatively new disease entity, thus very limited data are currently available regarding its epidemiology. To date, several case series regarding clinical profiles of IgG4-SC have been published, including our study [1–3]; however, no epidemiological studies illustrating the incidence and prevalence of IgG4-SC have been conducted. In this review, epidemiological and clinical features of IgG4-SC are discussed in general and are based mainly on data in the Japanese population.

References

  1. 1.
    Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.CrossRefPubMedGoogle Scholar
  2. 2.
    Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014;109:1675–83.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Tanaka A, Tazuma S, Okazaki K, Nakazawa T, Inui K, Chiba T, et al. Clinical features, response to treatment, and outcomes of IgG4-related Sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15:920–926.e923.CrossRefPubMedGoogle Scholar
  4. 4.
    Kanno A, Masamune A, Okazaki K, Kamisawa T, Kawa S, Nishimori I, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015;44:535–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Kawa S, Hamano H, Umemura T, Kiyosawa K, Uehara T. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res. 2007;37(Suppl 3):S487–95.CrossRefPubMedGoogle Scholar
  6. 6.
    Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2014;21:43–50.CrossRefPubMedGoogle Scholar
  8. 8.
    Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536–42.CrossRefPubMedGoogle Scholar
  10. 10.
    de Buy Wenniger LJ, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014;60:1453–4.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2019

Authors and Affiliations

  1. 1.Department of MedicineTeikyo University School of MedicineTokyoJapan

Personalised recommendations